BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19908304)

  • 1. Feasibility and safety of triple dose platelet collection by apheresis.
    Moog R
    J Clin Apher; 2009; 24(6):238-40. PubMed ID: 19908304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the performance of Trima Accel® v5.2 for the collection of concentrated high-dose platelet products and concurrent plasma from high platelet count donors, in Germany.
    Daskalakis M; Schulz-Huotari C; Burger M; Klink I; Umhau M
    J Clin Apher; 2012; 27(2):75-80. PubMed ID: 22362609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postdonation platelet counts are safe when collecting platelets with the Trima Accel using a postdonation platelet count target of > or =50,000 platelets/microL.
    Alex J; Roberts B; Raife T
    J Clin Apher; 2009; 24(5):215-7. PubMed ID: 19816960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Fenwal Amicus blood cell separator in double dose platelet collection.
    Gürak S; Arslan O
    Transfus Apher Sci; 2007 Feb; 36(1):69-72. PubMed ID: 17270496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality and safety of platelet apheresis concentrates produced with a new leukocyte reduction system.
    Riggert J; Humpe A; Simson G; Köhler M
    Vox Sang; 1998; 74(3):182-8. PubMed ID: 9595646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and clinicopathologic effects of plateletpheresis on healthy donor dogs.
    Callan MB; Appleman EH; Shofer FS; Mason NJ; Brainard BM; Groman RP
    Transfusion; 2008 Oct; 48(10):2214-21. PubMed ID: 18564392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective comparison of high-dose plateletpheresis with the latest apheresis systems on the same donors.
    Picker SM; Radojska SM; Gathof BS
    Transfusion; 2006 Sep; 46(9):1601-8. PubMed ID: 16965590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of adverse events in plateletpheresis donors in regional transfusion centre in North India.
    Patidar GK; Sharma RR; Marwaha N
    Transfus Apher Sci; 2013 Oct; 49(2):244-8. PubMed ID: 23830186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 3-year analysis of plateletpheresis donor deferral pattern in a tertiary health care institute: assessing the current donor selection criteria in Indian scenario.
    Tondon R; Pandey P; Chaudhry R
    J Clin Apher; 2008; 23(4):123-8. PubMed ID: 18615635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent platelet apheresis donations in volunteer donors with hemoglobin < 125 g/l are safe and efficient.
    Méndez A; Wägli F; Schmid I; Frey BM
    Transfus Apher Sci; 2007 Feb; 36(1):47-53. PubMed ID: 17234455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of donor factors contributing to plateletpheresis yields among apheresis platelet donors.
    Woodall WJ; Nguyen VQ; Tran MH
    J Clin Apher; 2014 Jun; 29(3):139-47. PubMed ID: 24222645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collection of hyperconcentrated platelets with Trima Accel.
    Ringwald J; Duerler T; Frankow O; Zimmermann R; Zingsem J; Strasser E; Antoon M; Eckstein R
    Vox Sang; 2006 Feb; 90(2):92-6. PubMed ID: 16430666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocytopenia in donors undergoing regular platelet apheresis with cell separators.
    Robbins G; Petersen CV; Brozović B
    Clin Lab Haematol; 1985; 7(3):225-30. PubMed ID: 4075737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I; Cepulić BG; Mazić S
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre- and post- donation haematological values in healthy donors undergoing plateletpheresis with five different systems.
    Das SS; Chaudhary R; Verma SK; Ojha S; Khetan D
    Blood Transfus; 2009 Jul; 7(3):188-92. PubMed ID: 19657482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of double- and triple-apheresis platelet product donation on apheresis donor platelet and white blood cell counts.
    Richa E; Krueger P; Burgstaler EA; Bryant SC; Winters JL
    Transfusion; 2008 Jul; 48(7):1325-32. PubMed ID: 18346017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Regular platelet donors--no risk to the donor].
    Offner R; Worschech W; Sänger W; Pachmann U
    Beitr Infusionsther Transfusionsmed; 1994; 32():341-4. PubMed ID: 9480122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequently used plateletpheresis techniques result in variable target yields and platelet recruitment of donors.
    Strasser EF; Schuster M; Egler K; Bauer J; Weisbach V; Ringwald J; Zimmermann R; Zingsem J; Eckstein R
    Transfusion; 2005 May; 45(5):788-97. PubMed ID: 15847670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective, paired crossover comparison of multiple, single-needle plateletpheresis procedures with the Amicus and Trima Accel cell separators.
    Fontana S; Mordasini L; Keller P; Taleghani BM
    Transfusion; 2006 Nov; 46(11):2004-10. PubMed ID: 17076857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of platelet parameters in healthy apheresis donors using the ADVIA 120.
    Ifran A; Haşimi A; Kaptan K; Nevruz O; Beyan C; Erbil K
    Transfus Apher Sci; 2005 Oct; 33(2):87-90. PubMed ID: 16139569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.